Sialadenosis in Bulimia: A New Treatment

July 11, 1993

Published By ACUTE Center for Eating Disorders

Objective: To see whether a cholinomimetic medication would help resolve the parotid gland enlargement associated with self-induced vomiting in bulimic patients.

Setting & Design: The medication was administered on an inpatient eating disorder unit to bulimic patients with refractory sialadenosis.Pilocarpine hydrochloride drops were administered orally at a dosage of 1.25 to 5.0 mg/d until the parotid gland enlargement was significantly reduced.

Results: There was a marked diminution in the size of the parotid gland enlargement.

Conclusion: Pilocarpine has proved to be beneficial in the treatment of sialadenosis in bulimic patients.

 To read the full abstract, visit the Archives of Otolaryngology Head and Neck Surgery.

  1. Mehler PS, Wallace JA. Sialadenosis in Bulimia. A New Treatment. Archives of Otolaryngology Head and Neck Surgery 119:787-789,1993. |